Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Period	Debt/Equity
2015-12-31	7.08
2016-12-31	6.23
2017-12-31	4.15
2018-12-31	3.38
2019-12-31	14.06
2020-12-31	2.10
2021-12-31	2.68
2022-12-31	3.73
2023-12-31	2.53
2024-12-31	1.55

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PODD	$204.31	+0.00%	0.89M
3
4
5

Insulet Corporation (PODD) Debt to Equity Ratio

Debt to Equity Ratio Data

Get Insulet Corporation Data in Excel

More PODD Financial Data